首页> 外国专利> DERIVATIVES OF 2-CICLOHEXIL-4-FENIL-1H-IMIDAZOL AS LIGANDS OF THE Y5 NEUROPEPTIDE RECEIVER.

DERIVATIVES OF 2-CICLOHEXIL-4-FENIL-1H-IMIDAZOL AS LIGANDS OF THE Y5 NEUROPEPTIDE RECEIVER.

机译:作为Y5神经肽受体的配体的2-环己基-4-芬尼-1H-咪唑的衍生物。

摘要

A compound of ** formula ** or a pharmaceutically acceptable salt thereof, wherein: R1: represents hydrogen, C1-C8 alkyl. C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy, C1-C8 alkanoyloxy, C1-C8 carbonate, C1-C8 carbamate, C1-C8 alkylthio, halogen-C1-C8 alkyl, halogen-C1-C8 alkoxy, hydroxyalkyl C1-C8, C1-C8 hydroxyalkoxy, mono or di (C1-C8) alkyl-amino, C1-C8 alkanoyl, (C1-C8) alkoxy-carbonyl, -COOH, -SO2NH2, mono or dialkylsulfonamido, -C (O ) NH2 or mono or di (C1-C8) alkylcarboxamido; R2 represents 0 to 5 ring substituents, each substituent independently selected from hydrogen, halogen, hydroxy, amino, cyano, nitro, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy, alkanoyloxy C1-C8, C1-C8 carbonate, C1-C8 carbamate, C1-C8 alkylthio, halo-C1-C8 alkyl, halogen-C1-C8 alkoxy, C1-C8 hydroxyalkyl, C1-C8 hydroxyalkoxy, mono or di-alkyl (C1 -C8) -amino, C1-C8 alkanoyl, (C1-C8) alkoxy -carbonyl, -COOH, -SO2NH2, mono or dialkylsulfonamido, -C (O) NH2 or mono or di-(C1-C8) alkylcarboxamido; A represents -C (O) - or -CH2-; R3 represents: (i) hydrogen; (ii) C1-C8 alkyl, optionally substituted with 1 to 8 substituents that are independently selected from halogen, hydroxyl, carbocyclic groups and heterocyclic groups, wherein each carbocyclic or heterocyclic group contains 3 to 10 ring members; or (iii) a link to R4 forming a heterocyclic group having 1 to 3 condensed or pendant rings, and each ring contains 5 to 10 members in the ring, in which each ring is optionally substituted with 1 to 5 substituents that are independently selected from halogen, cyano, nitro, C1-C8 alkyl, C2-C8 alkenyl, C2-C8 alkynyl, C1-C8 alkoxy, C1-C8 alkylthio, hydroxy, amino, mono or di-alkyl (C1-C8 ) -amino, halogen-C1-C8 alkyl, halogen-C1-C8 alkoxy, C1-C8 hydroxyalkyl, C1-C8 hydroxyalkoxy, C2-C8 alkanoyl, (C1-C8) alkoxycarbonyl, -COOH, -SO2NH2, mono or dialkylsulfonamido, -C (O) NH2 or mono odi-(C1-C8) alkylcarboxamido; X represents a bond, -S (O) 2-, -C (O) - or -NHC (O) -
机译:式**的化合物或其药学上可接受的盐,其中:R 1:代表氢,C 1 -C 8烷基。 C 2 -C 8烯基,C 2 -C 8炔基,C 1 -C 8烷氧基,C 1 -C 8烷酰氧基,C 1 -C 8碳酸酯,C 1 -C 8氨基甲酸酯,C 1 -C 8烷硫基,卤素-C 1 -C 8烷基,卤素-C 1 -C 8烷氧基,羟烷基C 1 -C 8,C 1 -C 8羟基烷氧基,单或二(C 1 -C 8)烷基氨基,C 1 -C 8烷酰基,(C 1 -C 8)烷氧基羰基,-COOH,-SO 2 NH 2,单或二烷基磺酰胺基,-C(O) NH 2或单或二(C 1 -C 8)烷基甲酰胺基; R2代表0至5个环取代基,每个取代基独立地选自氢,卤素,羟基,氨基,氰基,硝基,C1-C8烷基,C2-C8链烯基,C2-C8炔基,C1-C8烷氧基,烷酰氧基C1-C8, C1-C8碳酸酯,C1-C8氨基甲酸酯,C1-C8烷硫基,卤代C1-C8烷基,卤素-C1-C8烷氧基,C1-C8羟烷基,C1-C8羟基烷氧基,单或二烷基(C1-C8)-氨基,C 1 -C 8烷酰基,(C 1 -C 8)烷氧基-羰基,-COOH,-SO 2 NH 2,单或二烷基磺酰胺基,-C(O)NH 2或单或二-(C 1 -C 8)烷基甲酰胺基; A代表-C(O)-或-CH 2-; R3代表:(i)氢; (ii)C 1 -C 8烷基,其任选地被1至8个独立地选自卤素,羟基,碳环基团和杂环基团的取代基取代,其中每个碳环或杂环基团包含3至10个环成员; (iii)与R4连接形成具有1至3个稠环或侧链的杂环基,并且每个环在环中包含5至10个成员,其中每个环任选地被1至5个独立地选自以下的取代基取代卤素,氰基,硝基,C1-C8烷基,C2-C8烯基,C2-C8炔基,C1-C8烷氧基,C1-C8烷硫基,羟基,氨基,单或二烷基(C1-C8)-氨基,卤素- C 1 -C 8烷基,卤素-C 1 -C 8烷氧基,C 1 -C 8羟烷基,C 1 -C 8羟基烷氧基,C 2 -C 8烷酰基,(C 1 -C 8)烷氧基羰基,-COOH,-SO 2 NH 2,单或二烷基磺酰胺基,-C(O)NH 2或单-(-C 1 -C 8)烷基甲酰胺基; X表示键,-S(O)2-,-C(O)-或-NHC(O)-

著录项

  • 公开/公告号ES2280472T3

    专利类型

  • 公开/公告日2007-09-16

    原文格式PDF

  • 申请/专利权人 NEUROGEN CORPORATION;

    申请/专利号ES20020023469T

  • 申请日2002-10-21

  • 分类号A61K31/4164;A61K31/4178;A61K31/4439;A61K31/5377;A61K51;A61P1/04;A61P1/06;A61P3/04;A61P3/10;A61P9;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P9/14;A61P11/06;A61P11/08;A61P13/10;A61P13/12;A61P15/08;A61P15/10;A61P25;A61P25/02;A61P25/04;A61P25/18;A61P25/22;A61P25/24;C07D233/54;C07D233/64;C07D401/06;C07D401/12;C07D403/06;C07D405/12;

  • 国家 ES

  • 入库时间 2022-08-21 20:54:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号